肺癌耐药机制研究进展

被引：9

作者：

李玉光

马利军

张罗献

机构：

[1] 河南省人民医院呼吸科

来源：

中国综合临床 | 2011年 / 01期

关键词：

肺癌; 耐药; 化学治疗;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

<正>肺癌是最常见的恶性肿瘤之一,75%的患者就诊时已是晚期,失去了手术治疗的机会。因此,化学治疗及分子靶向治疗成为肺癌的重要治疗手段,可以显著延长患者的生存期,减轻症状,提高生活质量。然而肿瘤细胞对药物的耐受

引用

收藏

相关论文

共 9 条

[1]

Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin [J].

Lee, Myoung Woo ;

Kim, Dae Seong ;

Min, Na Young ;

Kim, Heung Tae .

INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) :2380-2384

[2]

PTEN expression in non–small-cell lung cancer: evaluating its relation to tumor characteristics; allelic loss; and epigenetic alteration.[J].Carmen J. Marsit;Shichun Zheng;Kenneth Aldape;Philip W. Hinds;Heather H. Nelson;John K. Wiencke;Karl T. Kelsey.Human Pathology.2005, 7

[3]

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib [J].

Pao, W ;

Wang, TY ;

Riely, GJ ;

Miller, VA ;

Pan, QL ;

Ladanyi, M ;

Zakowski, MF ;

Heelan, RT ;

Kris, MG ;

Varmus, HE .

PLOS MEDICINE, 2005, 2 (01) :57-61

[4]

Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review) [J].

Wang, GD ;

Reed, E ;

Li, QQ .

ONCOLOGY REPORTS, 2004, 12 (05) :955-965

[5]

Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer [J].

Boldrini, L ;

Faviana, P ;

Gisfredi, S ;

Di Quirico, D ;

Lucchi, M ;

Mussi, A ;

Angeletti, CA ;

Baldinotti, F ;

Fogli, A ;

Simi, P ;

Basolo, F ;

Pingitore, F ;

Fontanini, G .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (01) :155-159

[6]

In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II [J].

Mistry, P ;

Stewart, AJ ;

Dangerfield, W ;

Baker, M ;

Liddle, C ;

Bootle, D ;

Kofler, B ;

Laurie, D ;

Denny, WA ;

Baguley, B ;

Charlton, PA .

ANTI-CANCER DRUGS, 2002, 13 (01) :15-28

[7]

Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines [J].

Heim, MM ;

Eberhardt, W ;

Seeber, S ;

Müller, MR .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (04) :198-204

[8]

晚期非小细胞肺癌组织中ERCC-1、Metallothionein、p53表达与铂类耐药性及预后的相关性分析 [J].

黄培钰 ;

梁小曼 ;

林素瑕 ;

罗荣臻 ;

侯景辉 ;

张力 .

癌症, 2004, (07) :845-850

[9]

PTEN mutations are common in sporadic microsatellite stable colorectal cancer..Nassif NT; Lobo GP; Wu X; et al;.Oncogene.2004,